Risedronate activity in the fetal and neonatal mouse

Keyphrases

• Neonatal Mice 100%
• Risedronate 100%
• Fetal Mice 100%
• Calcium Release 66%
• Bisphosphonates 50%
• Calvaria 50%
• Intact Parathyroid Hormone (iPTH) 50%
• Paget's Disease of Bone 33%
• Chronic Infection 16%
• Oral Administration 16%
• Pre-incubation 16%
• Hearing Impairment 16%
• Drug Class 16%
• Bone Remodeling 16%
• Cholesteatoma 16%
• Bone Resorption 16%
• Placental Transfer 16%
• Incubation Media 16%
• Bone Turnover 16%
• Otosclerosis 16%
• Otitis Media 16%
• Osteoporosis 16%
• Antiresorptive 16%
• In Vivo Exposure 16%
• Vestibular Disorders 16%
• Bone Modeling 16%
• Third Generation 16%
• Culture System 16%
• In Vitro Effect 16%
• Hypercalcemia of Malignancy 16%
• Biologically Effective 16%
• Lacteal 16%
• In Vitro Release 16%
• Lactational Transfer 16%

Medicine and Dentistry

• Risedronic Acid 100%
• In Vitro 66%
• Calcium Transport 66%
• Bisphosphonate 50%
• Parathyroid Hormone 50%
• Diseases 50%
• Paget Bone Disease 33%
• Calvaria 33%
• Infection 16%
• Cancer 16%
• Oral Drug Administration 16%
• Incubation 16%
• Disease 16%
• Osteolysis 16%
• Cholesteatoma 16%
• Bone Turnover 16%
• Hearing Impairment 16%
• Otosclerosis 16%
• Osteoporosis 16%
• Hypercalcaemia 16%
• Chronic Otitis Media 16%
• Vestibular Disorder 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Risedronic Acid 100%
• Bisphosphonic Acid Derivative 50%
• Parathyroid Hormone 50%
• Diseases 50%
• Paget Bone Disease 33%
• Infection 16%
• Hearing Impairment 16%
• Hypercalcaemia 16%
• Vestibular Disorder 16%
• Cholesteatoma 16%
• Chronic Otitis Media 16%
• Otosclerosis 16%
• Oral Administration 16%